Cyclo Therapeutics, Inc. (CYTHW) 是一家上市公司 属于 医疗保健 板块，经营于 制药 - 专科与仿制药 行业. 公司总部位于 Gainesville, FL, 美国. 现任CEO为 N. Scott Fine.
CYTHW 拥有 IPO日期为 2020-12-18, 8 名全职员工, 在 NASDAQ Capital Marke, 市值为 $899.37K.
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
